Director & Chief Executive Officer
Director & Chief Executive Officer at Rapport Therapeutics, Inc., filing insider transactions between 2026-06-29 and 2026-09-23.
| SEC ↗ |
| 2026-09-08 | RAPP | Sale | 7,141 | $45.55 | $325K | SEC ↗ |
| 2026-09-08 | RAPP | Sale | 1,069 | $46.01 | $49K | SEC ↗ |
| 2026-08-25 | RAPP | Sale | 18.9K | $49.57 | $938K | SEC ↗ |
| 2026-08-11 | RAPP | Sale | 19.5K | $48.04 | $937K | SEC ↗ |
| 2026-08-11 | RAPP | Sale | 3,664 | $46.90 | $172K | SEC ↗ |
| 2026-08-11 | RAPP | Sale | 5,794 | $48.62 | $282K | SEC ↗ |
| 2026-08-10 | RAPP | Sale | 8,370 | $46.75 | $391K | SEC ↗ |
| 2026-08-10 | RAPP | Sale | 14.2K | $45.97 | $651K | SEC ↗ |
| 2026-07-27 | RAPP | Sale | 2,203 | $42.11 | $93K | SEC ↗ |
| 2026-07-27 | RAPP | Sale | 7 | $42.73 | $299 | SEC ↗ |
| 2026-07-14 | RAPP | Sale | 2,729 | $40.57 | $111K | SEC ↗ |
| 2026-07-14 | RAPP | Sale | 5,481 | $39.72 | $218K | SEC ↗ |
| 2026-06-29 | RAPP | Sale | 876 | $40.34 | $35K | SEC ↗ |
| 2026-06-29 | RAPP | Sale | 7,344 | $39.77 | $292K | SEC ↗ |